Bionanao Genomics Inc (BNGO)

[Avoid]

$BNGO $BNGOW

Bionano estimated that the discovery research and cytogenetics markets offer it the opportunity to sell up to approximately 8,500 Saphyr systems for a total of $2.1 billion. In addition, each Saphyr system has the potential to create recurring revenues ranging from about $75,000 to $150,000 per year, for a total of $0.6 billion to $1.3 billion per year. Thus, the firm estimates the size of its total currently addressable genome analysis market to be between $2.7 billion and $3.4 billion.